Liver Cancer
Title Abbreviation
Liver Cancer
Electronic ISSN
1664-5553
Readership
Biomedical Researchers, Clinical Pharmacologists, Clinicians, Hepatologists, Molecular Biologists, Oncologists, Pharmaco-Epidemiologists, Pharmacologists, Researchers
Scope
Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal Liver Cancer serves the growing need to better understand the causes, mechanisms and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy, of the disease. Liver Cancer publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.
Sponsoring Association(s)
Asia-Pacific Primary Liver Cancer Expert Association (APPLE)
Publisher Name
Karger Publishers
Impact Factor
JCR Categories/Rank
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines